Hostname: page-component-77f85d65b8-grvzd Total loading time: 0 Render date: 2026-03-29T09:00:25.063Z Has data issue: false hasContentIssue false

Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health

Published online by Cambridge University Press:  22 January 2021

Sarah Berglas*
Affiliation:
Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Ave, Ottawa, Ontario, Canada K1S 5S8
Nadine Vautour
Affiliation:
Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Ave, Ottawa, Ontario, Canada K1S 5S8
Daryl Bell
Affiliation:
Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Ave, Ottawa, Ontario, Canada K1S 5S8
*
Author for correspondence: Sarah Berglas, E-mail: sarahb@cadth.ca
Rights & Permissions [Opens in a new window]

Abstract

In recognition of patients’ roles using, and contributing to, a publicly funded health system, the Canadian Agency for Drugs and Technologies in Health (CADTH) created a Patient and Community Advisory Committee. Twelve members bring lived experiences of chronic illness, progressive illness, mental illness, trauma, traveling long distances for treatment, and caregiving to an ill child, parent, or spouse. Members contribute their own insights and ideas but do not represent specific organizations or viewpoints. This paper explores how CADTH determined the committee's role, whether to have individuals or organizations as members, and how to recruit for diversity. The creation of this committee is changing how CADTH engages with patients.

Information

Type
Perspective
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - SA
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike licence (http://creativecommons.org/licenses/by-nc-sa/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the same Creative Commons licence is included and the original work is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use.
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press